Literature DB >> 4031961

Visual evoked potentials in ataxia telangiectasia.

R Sridharan, B C Mehta.   

Abstract

Pattern reversal visual evoked potentials (VEPs) elicited in four patients with ataxia telangiectasia revealed normal results in two and absent responses in two. The pathogenesis of the VEP abnormalities is discussed. It is surmised that the VEP changes reflect progressive degeneration of the nerve fibres in the anterior visual pathway, as in Friedreich's ataxia.

Entities:  

Mesh：

Year:  1985        PMID： 4031961     DOI： 10.1007/bf00313896

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


  7 in total

1.  Voluntary alteration of visual evoked potentials.

Authors:  J Bumgartner; C M Epstein
Journal:  Ann Neurol       Date:  1982-11       Impact factor: 10.422

2.  Voluntary alteration of evoked potentials?

Authors:  K H Chiappa; C Yiannikas
Journal:  Ann Neurol       Date:  1982-11       Impact factor: 10.422

3.  Louis-bar's syndrome (ataxia-telangiectasia). Neuropathologic observations.

Authors:  G B Solitare; V F Lopez
Journal:  Neurology       Date:  1967-01       Impact factor: 9.910

4.  Friedreich's ataxia: a clinical and genetic study of 90 families with an analysis of early diagnostic criteria and intrafamilial clustering of clinical features.

Authors:  A E Harding
Journal:  Brain       Date:  1981-09       Impact factor: 13.501

5.  Visual evoked potentials in spinocerebellar degenerations.

Authors:  R Sridharan
Journal:  Clin Neurol Neurosurg       Date:  1983       Impact factor: 1.876

6.  Visual involvement in Friedreich's ataxia and hereditary spastic ataxia. A clinical and visual evoked response study.

Authors:  I R Livingstone; F L Mastaglia; R Edis; J W Howe
Journal:  Arch Neurol       Date:  1981-02

7.  The incidence and nature of visual pathway involvement in Friedreich's ataxia. A clinical and visual evoked potential study of 22 patients.

Authors:  W M Carroll; A Kriss; M Baraitser; G Barrett; A M Halliday
Journal:  Brain       Date:  1980-06       Impact factor: 13.501
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.